Indivior Pharmaceuticals Inc (INDV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 195,000 | 319,000 | 316,000 | 774,000 | 1,102,000 |
| Marketable Securities | N/A | 1,000 | 94,000 | 119,000 | N/A |
| Receivables | 255,000 | 287,000 | 254,000 | 225,000 | 215,000 |
| Inventories | 153,000 | 167,000 | 135,000 | 114,000 | 95,000 |
| Other current assets | 15,000 | 22,000 | 467,000 | 27,000 | 32,000 |
| TOTAL | $652,000 | $827,000 | $1,266,000 | $1,259,000 | $1,444,000 |
| Non-Current Assets | |||||
| PPE Net | 144,000 | 100,000 | 84,000 | 54,000 | 58,000 |
| Investments And Advances | 28,000 | 27,000 | 41,000 | 98,000 | 0 |
| Intangibles | 2,000 | 6,000 | 13,000 | 70,000 | 82,000 |
| Other Non-Current Assets | 376,000 | 355,000 | 356,000 | 288,000 | 248,000 |
| TOTAL | $550,000 | $488,000 | $494,000 | $510,000 | $388,000 |
| Total Assets | $1,201,000 | $1,316,000 | $1,760,000 | $1,769,000 | $1,832,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 29,000 | 18,000 | 3,000 | 3,000 | 3,000 |
| Accounts payable and accrued liabilities | 250,000 | 216,000 | 204,000 | 617,000 | 720,000 |
| Accrued Expenses | 624,000 | 661,000 | 1,027,000 | N/A | N/A |
| Other current liabilities | N/A | 11,000 | 40,000 | 382,000 | 66,000 |
| TOTAL | $914,000 | $924,000 | $1,290,000 | $1,019,000 | $804,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 290,000 | 315,000 | 237,000 | 237,000 | 239,000 |
| Other Non-Current Liabilities | 95,000 | 415,000 | 424,000 | 462,000 | 586,000 |
| TOTAL | $385,000 | $730,000 | $661,000 | $699,000 | $825,000 |
| Total Liabilities | $1,300,000 | $1,652,000 | $1,951,000 | $1,718,000 | $1,629,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 125,065 | N/A | N/A | N/A | N/A |
| Common Shares | 62,000 | 62,000 | 68,000 | 68,000 | 70,000 |
| Retained earnings | -243,000 | -443,000 | -295,000 | 1,303,000 | 1,438,000 |
| Other shareholders' equity | -29,000 | -46,000 | -52,000 | -1,328,000 | -1,312,000 |
| TOTAL | $-98,000 | $-337,000 | $-191,000 | $51,000 | $203,000 |
| Total Liabilities And Equity | $1,202,000 | $1,315,000 | $1,760,000 | $1,769,000 | $1,832,000 |